{"entity":{"id":"omicxscreen","kind":"drug","name":"OmicXScreen","aka":[],"tldr":"OmicXScreen is an investigational blood test from OmicXHealth that reads DNA patterns to look for early liver cancer, with other cancers in development.","summary":"OmicXScreen is the early cancer detection platform of OmicXHealth. The company reports preclinical validation for hepatocellular carcinoma, a lung cancer classifier and proof of concept in six cancer types. The National Cancer Institute funds an SBIR project on the test for early hepatocellular carcinoma and oesophageal cancer detection (1R43CA310377-01A1). It is not cleared or approved by a regulator.","status":"emerging","asOf":"2026-11-04","links":[{"label":"OmicXHealth","url":"https://www.omicxhealth.com/"},{"label":"NIH RePORTER: 1R43CA310377-01A1","url":"https://reporter.nih.gov/project-details/11404601"}],"tags":["pipeline"],"related":[],"cancers":[],"sections":[],"technologies":["cfdna-methylation-testing"],"targets":[],"drugs":[],"companies":["omicxhealth"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"provenance":{"editedBy":"OnCo startup monitors","editedOn":"2026-11-04"},"modality":"Blood test (whole-genome sequencing with DNA methylation analysis and machine learning)","mechanism":"Sequences cell-free DNA from a blood sample once across the whole genome and analyses methylation patterns in software with machine-learning models to detect early cancer.","approvals":[],"mechanismSteps":[],"toxicity":[],"access":[],"regulatoryEvents":[]},"route":"/drugs/omicxscreen/","neighbours":{"technology":[{"id":"cfdna-methylation-testing","kind":"technology","name":"Cell-free DNA methylation tests","route":"/technologies/cfdna-methylation-testing/"}],"company":[{"id":"omicxhealth","kind":"company","name":"OmicXHealth","route":"/companies/omicxhealth/"}]}}